AstraZeneca, Daiichi’s Enhertu steps into the FDA’s fast lane for new stomach cancer use

AstraZeneca, Daiichi’s Enhertu steps into the FDA’s fast lane for new stomach cancer use
aliu
Wed, 10/28/2020 – 09:13